Genome biol 2008, 9:R74 PubMedCentralPubMedCrossRef 43 Taghavi S

Genome biol 2008, 9:R74.PubMedCentralPubMedCrossRef 43. Taghavi S, Garafola EPZ-6438 solubility dmso C, Monchy S, Newman L, Hoffman A, Weyens N, Barac T, Vangronsveld J, van der Lelie D: Genome survey and characterization of endophytic bacteria exhibiting a beneficial effect on growth and development of poplar

trees. Appl Environ Microbiol 2009, 75:748–757.PubMedCentralPubMedCrossRef 44. Yen MR, Lin NT, Hung CH, Choy KT, Weng SF, Tseng YH: oriC region and replication termination site, dif , of the Xanthomonas campestris pv. campestris 17 chromosome. Appl Environ Microbiol 2002, 68:2924–2933.PubMedCentralPubMedCrossRef 45. Yu A, Haggård-Ljungquist E: Characterization of the binding sites of two proteins involved in the bacteriophage P2 site-specific recombination selleck compound system. J Bacteriol 1993, 175:1239–1249.PubMedCentralPubMed

46. Miller JH: Experiments in molecular genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1972. 47. Sambrook J, Russell DW: Molecular cloning: a laboratory manual. 3rd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 2001. 48. Lee CN, Hu RM, Chow TY, Lin JW, Chen HY, Tseng YH, Weng SF: Comparison of genomes of three Xanthomonas oryzae bacteriophages. BMC genomics 2007, 8:442.PubMedCentralPubMedCrossRef 49. Lee CN, Lin JW, Weng SF, Tseng YH: Genomic characterization of the intron-containing T7-like phage phiL7 of Xanthomonas campestris . Appl Environ Microbiol 2009, 75:7828–7837.PubMedCentralPubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions SFW designed the experiments. CNL and HCC carried out the wet lab. TTT and CNL performed bioinformatic analyses. JWL and TTT edited the manuscript. All authors read and approved

Clomifene the final manuscript.”
“Background The Escherichia coli uropathogenic-specific protein (Usp) has been shown to be associated with E. coli strains that provoke pyelonephritis, prostatitis and bacteraemia, and with increased virulence and fitness of pathogenic strains of E. coli[1–4]. Nucleotide sequence analysis has shown approximately 45% sequence identity of the Usp C-terminal region with that of the E. coli bacteriocin colicin E7, which has nuclease activity, while the Usp N-terminal region is similar to the Type VI protein secretion system component (Hcp like) [5–7]. It has been proposed that Usp acts as a bacteriocin against competing E. coli strains and that it also enhances infectivity in the urinary tract. Recently, we demonstrated the genotoxic find more activity of Usp against mammalian cells [5, 8]. To protect the colicin-producing cell from its own toxin, colicin-encoding operons generally harbour one cognate immunity gene [9]. Colicins and their immunity proteins have some of the strongest protein-protein affinities, which result in the formation of stable colicin–immunity protein complexes [10, 11].

Comments are closed.